Sunscreen Efficacy Against the Reccurence of Lesions Post-sun Exposure in Acneic Subjects

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

July 16, 2020

Primary Completion Date

November 9, 2020

Study Completion Date

November 9, 2020

Conditions
Acne
Interventions
OTHER

RV4857A

RV4857A formula CD2110 is a sunscreen product

Trial Locations (1)

1750-182

PhD Trials®, Lisbon

All Listed Sponsors
lead

Pierre Fabre Dermo Cosmetique

INDUSTRY

NCT05168397 - Sunscreen Efficacy Against the Reccurence of Lesions Post-sun Exposure in Acneic Subjects | Biotech Hunter | Biotech Hunter